What are the treatment options for hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Hair Loss

The most effective treatment for hair loss depends on the specific type of alopecia, with minoxidil being the first-line treatment for androgenetic alopecia, intralesional corticosteroids for alopecia areata, and addressing underlying causes for telogen effluvium. 1

Types of Hair Loss and Diagnosis

  • Hair loss (alopecia) can be categorized as nonscarring (diffuse, patterned, or focal) or scarring, with proper diagnosis guiding treatment selection 1
  • Diagnostic evaluation should exclude conditions like trichotillomania, tinea capitis, scarring alopecia, telogen effluvium, anagen effluvium, lupus erythematosus, and secondary syphilis 2, 3
  • Dermoscopy can aid diagnosis of alopecia areata by revealing regular round yellow dots in areas of hair loss and dystrophic hairs with broken ends 3
  • Laboratory testing may include thyroid function, iron stores, vitamin D and zinc levels for suspected endocrine-related alopecia 3

Treatment Options by Type of Alopecia

Androgenetic Alopecia (Most Common Form)

  • Topical minoxidil is FDA-approved as first-line treatment for both men and women 1, 4
  • Oral finasteride is approved for male pattern hair loss only 1, 4
  • Hormonal therapies like 5-alpha-reductase inhibitors (finasteride, dutasteride), spironolactone, and bicalutamide may be considered for hormone-related hair loss 5

Alopecia Areata

  • Spontaneous remission occurs in up to 80% of patients with limited patchy hair loss of short duration (<1 year), making no treatment a legitimate option 2
  • Intralesional corticosteroids are recommended for limited patchy alopecia areata 2
    • Triamcinolone acetonide (5-10 mg/mL) or hydrocortisone acetate (25 mg/mL) injected just beneath the dermis can stimulate regrowth 2
    • Studies show 62% of patients achieved full regrowth with monthly injections, with better response in those with fewer than five patches of <3 cm diameter 2
  • Topical corticosteroids have limited evidence of effectiveness but are widely used 2
    • Clobetasol propionate foam (0.05%) showed better regrowth compared to vehicle in one study 2
    • Folliculitis is a common side effect of potent topical steroids 2

Telogen Effluvium

  • Typically self-limited once the precipitating cause (stress, physical trauma, medications) is removed 6, 4
  • Treatment focuses on addressing the underlying trigger rather than specific hair treatments 7

Other Types

  • Tinea capitis requires oral antifungal treatment 1, 6
  • Traction alopecia improves by reducing tension on hair 1
  • Trichotillomania requires treatment of the underlying psychiatric condition 6

Psychological Aspects and Support

  • Hair loss can have significant psychological effects, impacting quality of life and potentially leading to anxiety and depression 1, 5
  • Patient education about the nature and course of the disease, along with available treatments, is essential 2, 3
  • Contact with patient support groups can help individuals cope with the changing aspects of alopecia 3

Important Considerations

  • An overriding consideration in management is that while alopecia may have serious psychological effects, it generally has no direct impact on general health that would justify hazardous treatments of unproven efficacy 2
  • Many treatments can induce hair growth but none has been shown to alter the long-term course of diseases like alopecia areata 2
  • For long-standing extensive alopecia with poor prognosis, wigs may be a better option than treatments unlikely to be effective 2
  • Treatment expectations should be realistic, as regrowth cannot be expected within 3 months of development of any individual patch in alopecia areata 2

References

Research

Hair Loss: Diagnosis and Treatment.

American family physician, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Évaluation et Prise en Charge de la Perte Excessive de Cheveux

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Common hair loss disorders.

American family physician, 2003

Research

Hair Loss: Common Causes and Treatment.

American family physician, 2017

Research

Alopecia in women.

American family physician, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.